45 participants
Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-13
- Start Date:
- 2014-10-10
- Completion:
- 2020-03-30
Conditions
- Recurrent Hodgkin Lymphoma
- Refractory Hodgkin Lymphoma
Interventions
- DRUG
- OTHER